Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1128/IAI.02955-14

http://scihub22266oqcxt.onion/10.1128/IAI.02955-14
suck pdf from google scholar
C4333456!4333456 !25547793
unlimited free pdf from europmc25547793
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid25547793
      Infect+Immun 2015 ; 83 (3 ): 986-95
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • New role for human ?-defensin 5 in the fight against hypervirulent Clostridium difficile strains #MMPMID25547793
  • Furci L ; Baldan R ; Bianchini V ; Trovato A ; Ossi C ; Cichero P ; Cirillo DM
  • Infect Immun 2015[Mar]; 83 (3 ): 986-95 PMID25547793 show ga
  • Clostridium difficile infection (CDI), one of the most common hospital-acquired infections, is increasing in incidence and severity with the emergence and diffusion of hypervirulent strains. CDI is precipitated by antibiotic treatment that destroys the equilibrium of the gut microbiota. Human ?-defensin 5 (HD5), the most abundant enteric antimicrobial peptide, is a key regulator of gut microbiota homeostasis, yet it is still unknown if C. difficile, which successfully evades killing by other host microbicidal peptides, is susceptible to HD5. We evaluated, by means of viability assay, fluorescence-activated cell sorter (FACS) analysis, and electron microscopy, the antimicrobial activities of ?-defensins 1 and 5 against a panel of C. difficile strains encompassing the most prevalent epidemic and hypervirulent PCR ribotypes in Europe (012, 014/020, 106, 018, 027, and 078). Here we show that (i) concentrations of HD5 within the intestinal physiological range produced massive C. difficile cell killing; (ii) HD5 bactericidal activity was mediated by membrane depolarization and bacterial fragmentation with a pattern of damage peculiar to C. difficile bacilli, compared to commensals like Escherichia coli and Enterococcus faecalis; and (iii) unexpectedly, hypervirulent ribotypes were among the most susceptible to both defensins. These results support the notion that HD5, naturally present at very high concentrations in the mucosa of the small intestine, could indeed control the very early steps of CDI by killing C. difficile bacilli at their germination site. As a consequence, HD5 can be regarded as a good candidate for the containment of hypervirulent C. difficile strains, and it could be exploited in the therapy of CDI and relapsing C. difficile-associated disease.
  • |Anti-Bacterial Agents/*pharmacology [MESH]
  • |Cell Membrane/drug effects [MESH]
  • |Clostridioides difficile/*drug effects/genetics/isolation & purification/ultrastructure [MESH]
  • |Enterococcus faecalis/drug effects/ultrastructure [MESH]
  • |Enterocolitis, Pseudomembranous/microbiology [MESH]
  • |Escherichia coli/drug effects/ultrastructure [MESH]
  • |Humans [MESH]
  • |Membrane Potentials/drug effects [MESH]
  • |Microbial Sensitivity Tests [MESH]
  • |Microbial Viability/drug effects [MESH]
  • |Ribotyping [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box